1H magnetic resonance spectroscopy of the prostate;1MR-spektroskopie der prostata: Ein überblick

Radiologe

Volumn 43, Issue 6, 2003, Pages 481-488

  Mueller Lisse, U G ^a   Scherr, M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cryo surgery; Hormone therapy; Magnetic resonance; Magnetic resonance spectroscopy; Prostate; Prostate cancer; Radiation therapy

Indexed keywords

CHLORINE; CITRIC ACID; CREATINE;

BIOCHEMISTRY; CANCER RADIOTHERAPY; CONTROLLED STUDY; CRYOSURGERY; ENERGY METABOLISM; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE; PROSTATE CARCINOMA; PROSTATE SURGERY; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOLOGY; REVIEW; TISSUE LEVEL;

EID: 0038605579     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-003-0902-y     Document Type: Review

References (40)

1. Bottomley PA(1987) Spatial localization in NMR-spectroscopy in vivo. Ann NY Acad Sci 508:333-348
2. Bottomley PA, Foster TB, Darrow RD (1984) Depth-resolved surface-coil-spectroscopy (DRESS) for in vivo 1H, 31P, and 13C NMR. J Magn Reson 59:338-342
3. Bottomley PA, Edelstein WA, Forster TH, Adams WA (1985) In vivo solvent suppressed localized hydrogen nuclear magnetic resonance spectroscopy: a window to metabolism? Proc Natl Acad Sci 82:2148-2152
4. Coakley FV, Kurhanewicz J, Lu Y, Jones KD, Swanson MG, Chang SD, Carroll PR, Hricak H (2002) Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 223:91-97
5. Costello LC, Franklin RB (1991a) Concepts of citrate production and secretion by prostate: 1. metabolic relationships. Prostate 18:25-46
6. Costello LC, Franklin RB (1991b) Concepts of citrate production and secretion by prostate: 2. hormonal relationships in normal and neoplastic prostate. Prostate 19:181-205
7. Costello LC, Franklin RB, Narayan P (1999) Citrate in the diagnosis of prostate cancer. Prostate 38:237-245
8. Cousins JP (1995) Clinical MR spectroscopy: fundamentals, current applications, and future potential. Am J Roentgenol AJR 164:1337-1347
9. Daly PF, Lyon RC, Faustino PJ et al.(1987) Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy. J Biol Chem 31:14875-14878
10. DiBiase SJ, Hosseinzadeh K, Gullapalli RP, Jacobs SC, Naslund MJ,Sklar GN, Alexander RB, Yu C (2002) Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer. Int J Rad Oncol Biol Phys 52:429-438
11. Ernst T, Hennig J (1991) Coupling effects in volume selective 1H spectroscopy of major brain metabolites. Magn Reson Med 21:82-96
12. Frahm J, Merboldt KD, Haenike W (1987) Localized proton spectroscopy using stimulated echos. J Magn Reson 72:502-508
13. Frahm J, Michaelis T, Merboldt KD, Bruhn H, Gyngell ML, Haenike W (1990) Improvements in localized proton NMR spectroscopy of human brain: water suppression, short echo times, and 1 ml resolution. J Magn Reson 90:464-473
14. Garcia-Segura JM, Sanchez-Chapado M, Ibarburen C, Viano J, Angulo JC, Gonzalez J, Rodriguez-Vallejo JM (1999) In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology. Magn Reson Imaging 17:755-765
15. Heerschap A, Jager GJ, van der Graaf M, Barentsz JO, Ruijs SH (1997) Proton MR spectroscopy of the normal human prostate with an endorectal coil and a double spin-echo pulse sequence. Magn Reson Med 37:204-213
16. Hore PJ (1983) Solvent suppression in Fourier transform nuclear magnetic resonance. J Magn Reson 55:283-300
17. Kaji Y, Kurhanewicz J, Hricak H, Sokolov DL, Huang LR, Nelson SJ, Vigneron DB (1998) Localizing prostate cancer in the presence of postbiopsy changes on MR imaging: role of proton MR spectroscopic imaging. Radiology 206:785-790
18. Kim JK, Kim DY, Lee YH, Sung NK, Chung DS, Kim OD, Kim KB (1998) In vivo differential diagnosis of prostate cancer and benign prostatic hyperplasia: localized proton magnetic resonance spectroscopy using external-body surface coils. Magn Reson Imaging 16:1281-1288
19. 3) spatial resolution. Radiology 198:795-805
20. Kurhanewicz J, Vigneron DB, Hricak H, Parivar F, Nelson SJ, Shinohara K, Carroll PR (1996b) Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Radiology 200:489-496
21. Kuroda K, Kaji Y, Mulkern RV, Takei N, Kitamura Y, Tamura M, Sugimura K (2002) MR observations of prostate metabolites at 3 tesla. Proc Internat Soc Magn Reson Med (ISMRM):1921
22. Liney GP, Turnbull LW, Lowry M, Turnbull LS, Knowles AJ, Horsman A (1997) In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI. Magn Reson Imaging 15:177-186
23. Luyten PR, Manen AJH, den Hollander JA (1988) In vivo 1H NMR-spectroscopy of the human brain by spatial localization and imaging techniques. Proc SMRM, Book of Abstracts 1:327
24. Males RG, Vigneron DB, Star-Lack J, Falbo SC, Nelson SJ, Hricak H, Kurhanewicz J (2000) Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging. Magn Reson Med 43:17-22
25. Maudsley AA, Hilal SK, Perman WH, Simon HE (1983) Spatially resolved high resolution spectroscopy by "four-dimensional" NMR. J Magn Reson 51:147-152
26. Menard C, Smith ICP, Somorjai RL, Leboldus L, Patel R, Littman C, Robertson SJ, Bezabeh T (2001) Magnetic resonance spectroscopy of the malignant prostate gland after radiotherapy: a histopathologicstudy of diagnostic validity. Int J Radiat Oncol Biol Phys 50:317-323
27. Moonen CTW, van Zijl PCM, Gillen J et al. (1989) Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy. NMR Biomed 2:201-208
28. Mueller-Lisse UG, Swanson MG, Vigneron DB, Hricak H, Bessette A, Males RG, Wood PJ, Noworolski S, Nelson SJ, Barken I, Carroll PR, Kurhanewicz J (2001a) Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging. Magn Reson Med 46.49-57
29. Mueller-Lisse UG, Vigneron DB, Hricak H, Swanson MG, Carroll PR, Bessette A, Scheidler J, Srivastava A, Males RG, Cha I, Kurhanewicz J (2001b) Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study. Radiology 221:380-390
30. Ordridge RJ, Bendall MR, Gordon RE, Conelly A (1985) Volume selection for in-vivo biological spectroscopy. In: Govil G, Khetrapal CL, Saran A (eds) Magnetic resonance in biology and medicine. Tata McGraw-Hill, New Dehli, pp 387-397
31. Ordridge RJ, Conelly A, Lohmann JAB (1986) Image selected in vivo spectroscopy (ISIS). A new technique for spatially selective NMR spectroscopy. J Magn Reson 66:283-294
32. Parivar F, Hricak H, Shinohara K, Kurhanewicz J, Vigneron DB, Nelson SJ, Carroll PR (1996) Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. Urology 48:594-599
33. Roell S, Scheenen TWJ, Klomp DWJ, van Dorsten F, Boettcher U, Heerschap A (2002) Robust retrospective fat removal for MR-spectroscopy of the prostate. Proc Internat Soc Magn Reson Med (ISMRM):1920
34. Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang RL, Zaloudek CJ, Nelson SJ, Carroll PR, Kurhanewicz J (1999) Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging - clinicopathologic study. Radiology 213:473-480
35. Schricker AA, Pauly JM, Kurhanewicz J, Swanson MG, Vigneron DB (2001) Dualband spectral-spatial RF pulses for prostate MR spectrsocopic imaging. Magn Reson Med 46:1079-1087
36. Star LJ, Nelson SJ, Kurhanewicz J, Huang LR, Vigneron DB (1997) Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn Reson Med 38:311-321
37. Vigneron DB, Males R, Noworolski S, Nelson SJ, Scheidler J, Sokolov D, Hricak H, Carroll P, Kurhanewicz J (1998) 3D MRSI of prostate cancer: correlation with histologic grade. Proc Internat Soc Magn Reson Med, Sixth Scientific Meeting and Exhibition, Sydney, Australia, April 18-24, 2:S488
38. Wefer AE, Hricak H, Vigneron DB, Coakley FV, Lu Y, Wefer J, Mueller-Lisse U, Carroll PR, Kurhanewicz J (2000) Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopy with step section histology. J Urol 164:400-404
39. Yu KK, Scheidler J, Hricak H, Vigneron DB, Zaloudek CJ, Males RG, Nelson SJ, Carroll PR, Kurhanewicz J (1999) Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 213:481-488
40. Zaider M, Zelefsky MJ, Lee EK, Zakian KL, Amols HI, Dyke J, Cohen G, Hu YC, Endi AK, Chui CS, Koutcher JA (2000) Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging. Int J Rad Oncol Biol Phys 47:1085-1096